125 related articles for article (PubMed ID: 24815438)
1. Effects of ubiquitin-conjugating enzyme 2C on invasion, proliferation and cell cycling of lung cancer cells.
Tang XK; Wang KJ; Tang YK; Chen L
Asian Pac J Cancer Prev; 2014; 15(7):3005-9. PubMed ID: 24815438
[TBL] [Abstract][Full Text] [Related]
2. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
Shuliang S; Lei C; Guangwu J; Changjie L
Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
Xie C; Powell C; Yao M; Wu J; Dong Q
Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
[TBL] [Abstract][Full Text] [Related]
5. [Effect of UBE2C overexpression on the proliferation of 293T cell line].
Huang X; Qiu YL; Tan JY; Qiao YF; Li M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):634-6. PubMed ID: 21651863
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.
Zhang Z; Liu P; Wang J; Gong T; Zhang F; Ma J; Han N
Med Oncol; 2015 May; 32(5):149. PubMed ID: 25832867
[TBL] [Abstract][Full Text] [Related]
7. UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma.
Li L; Li X; Wang W; Gao T; Shi Z
Biomed Pharmacother; 2018 Feb; 98():201-206. PubMed ID: 29268240
[TBL] [Abstract][Full Text] [Related]
8. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
Xiong Y; Lu J; Fang Q; Lu Y; Xie C; Wu H; Yin Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30914455
[TBL] [Abstract][Full Text] [Related]
9. Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.
Lin J; Raoof DA; Wang Z; Lin MY; Thomas DG; Greenson JK; Giordano TJ; Orringer MB; Chang AC; Beer DG; Lin L
Neoplasia; 2006 Dec; 8(12):1062-71. PubMed ID: 17217624
[TBL] [Abstract][Full Text] [Related]
10. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.
Wang H; Zhang C; Rorick A; Wu D; Chiu M; Thomas-Ahner J; Chen Z; Chen H; Clinton SK; Chan KK; Wang Q
Cancer Res; 2011 Jul; 71(14):4866-76. PubMed ID: 21593191
[TBL] [Abstract][Full Text] [Related]
11. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.
Zhang S; You X; Zheng Y; Shen Y; Xiong X; Sun Y
J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548081
[TBL] [Abstract][Full Text] [Related]
12. UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines.
Palumbo A; Da Costa NM; De Martino M; Sepe R; Pellecchia S; de Sousa VP; Nicolau Neto P; Kruel CD; Bergman A; Nasciutti LE; Fusco A; Pinto LF
Oncotarget; 2016 Oct; 7(40):65876-65887. PubMed ID: 27588470
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
Han Q; Zhou C; Liu F; Xu G; Zheng R; Zhang X
Oncol Rep; 2015 Aug; 34(2):877-83. PubMed ID: 26062455
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.
Rawat A; Gopal G; Selvaluxmy G; Rajkumar T
Cell Oncol (Dordr); 2013 Dec; 36(6):459-67. PubMed ID: 24072565
[TBL] [Abstract][Full Text] [Related]
15. Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro.
Wu X; Liang L; Dong L; Yu Z; Fu X
Mol Biol Rep; 2013 Mar; 40(3):2671-8. PubMed ID: 23247805
[TBL] [Abstract][Full Text] [Related]
16.
Liu Y; Zhao R; Chi S; Zhang W; Xiao C; Zhou X; Zhao Y; Wang H
Mol Cancer Res; 2020 Feb; 18(2):204-215. PubMed ID: 31662448
[TBL] [Abstract][Full Text] [Related]
17. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker.
Hao Z; Zhang H; Cowell J
Tumour Biol; 2012 Jun; 33(3):723-30. PubMed ID: 22170434
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.
Kariri Y; Toss MS; Alsaleem M; Elsharawy KA; Joseph C; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2022 Apr; 192(3):529-539. PubMed ID: 35124721
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.
Bose MV; Gopisetty G; Selvaluxmy G; Rajkumar T
Int J Radiat Biol; 2012 Sep; 88(9):629-34. PubMed ID: 22694363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
